2 results
Approved WMOCompleted
To confirm the safety of the Articulinx ICC by evaluating device- and procedure relates adverse events.
Approved WMORecruiting
Primary:•To compare the effect of venglustat with standard of care Fabry therapies on left ventricular mass index over 18 months in participants with Fabry disease and left ventricular hypertrophySecondary:•To evaluate the effect of venglustat on…